Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67001 - 67025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	CYP2A7	1549	downregulated	rosiglitazone results in decreased expression of CYP2A7 mRNA	19q13.2	A22609
Rosiglitazone	Approved Investigational	CYP2C18	1562	downregulated	rosiglitazone results in decreased expression of CYP2C18 mRNA	10q23.33	A22609
Rosiglitazone	Approved Investigational	CYP2J2	1573	upregulated	rosiglitazone results in increased expression of CYP2J2 mRNA	1p32.1	A24113
Rosiglitazone	Approved Investigational	CYP3A4	1576	upregulated	rosiglitazone results in increased expression of CYP3A4 mRNA	7q22.1	A14965 A20983 A22609
Rosiglitazone	Approved Investigational	CYP4F2	8529	downregulated	rosiglitazone results in decreased expression of CYP4F2 mRNA	19p13.12	A22609
Rosiglitazone	Approved Investigational	CYP7A1	1581	downregulated	rosiglitazone results in decreased expression of CYP7A1 mRNA	8q12.1	A22609
Rosiglitazone	Approved Investigational	DAO	1610	downregulated	rosiglitazone results in decreased expression of DAO mRNA	12q24.11	A22609
Rosiglitazone	Approved Investigational	DAP	1611	upregulated	rosiglitazone results in increased expression of DAP mRNA	5p15.2	A24100
Rosiglitazone	Approved Investigational	DAP3	7818	downregulated	rosiglitazone results in decreased expression of DAP3 mRNA	1q22	A24100
Rosiglitazone	Approved Investigational	DCSTAMP	81501	upregulated	rosiglitazone results in increased expression of DCSTAMP mRNA	8q22.3	A10216
Rosiglitazone	Approved Investigational	DCXR	51181	downregulated	rosiglitazone results in decreased expression of DCXR mRNA	17q25.3	A22609
Rosiglitazone	Approved Investigational	DDIT3	1649	upregulated	rosiglitazone results in increased expression of DDIT3 mRNA	12q13.3	A20427
Rosiglitazone	Approved Investigational	DDT	1652	downregulated	rosiglitazone results in decreased expression of DDT mRNA	22q11.23	A22609
Rosiglitazone	Approved Investigational	DDTL	100037417	downregulated	rosiglitazone results in decreased expression of DDTL mRNA	22q11.23	A22609
Rosiglitazone	Approved Investigational	DDX41	51428	upregulated	rosiglitazone results in increased expression of DDX41 mRNA	5q35.3	A24100
Rosiglitazone	Approved Investigational	DEDD	9191	upregulated	rosiglitazone results in increased expression of DEDD mRNA	1q23.3	A24100
Rosiglitazone	Approved Investigational	DHRS3	9249	upregulated	rosiglitazone results in increased expression of DHRS3 mRNA	1p36.21	A10216
Rosiglitazone	Approved Investigational	DHRS9	10170	upregulated	rosiglitazone results in increased expression of DHRS9 mRNA	2q31.1	A10216 A22609
Rosiglitazone	Approved Investigational	DLK1	8788	downregulated	rosiglitazone results in decreased expression of DLK1 mRNA	14q32.2	A24098
Rosiglitazone	Approved Investigational	DMPK	1760	downregulated	rosiglitazone results in decreased expression of DMPK mRNA	19q13.32	A10216
Rosiglitazone	Approved Investigational	DMWD	1762	downregulated	rosiglitazone results in decreased expression of DMWD mRNA	19q13.32	A10216
Rosiglitazone	Approved Investigational	DNAJC5B	85479	upregulated	rosiglitazone results in increased expression of DNAJC5B mRNA	8q13.1	A10216
Rosiglitazone	Approved Investigational	DPYS	1807	downregulated	rosiglitazone results in decreased expression of DPYS mRNA	8q22.3	A22609
Rosiglitazone	Approved Investigational	DUSP5	1847	upregulated	rosiglitazone results in increased expression of DUSP5 mRNA	10q25.2	A20427
Rosiglitazone	Approved Investigational	E2F4	1874	downregulated	rosiglitazone results in decreased expression of E2F4 mRNA	16q22.1	A24114

Displaying entries 67001 - 67025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability